Richter, V.; Klose, U.; Bender, B.; Rabehl, K.; Skardelly, M.; Schittenhelm, J.; Tabatabai, G.; Hempel, J.-M.; Ernemann, U.; Brendle, C.
Dynamic Susceptibility Perfusion Imaging for Differentiating Progressive Disease from Pseudoprogression in Diffuse Glioma Molecular Subtypes. J. Clin. Med. 2021, 10, 598.
https://doi.org/10.3390/jcm10040598
AMA Style
Richter V, Klose U, Bender B, Rabehl K, Skardelly M, Schittenhelm J, Tabatabai G, Hempel J-M, Ernemann U, Brendle C.
Dynamic Susceptibility Perfusion Imaging for Differentiating Progressive Disease from Pseudoprogression in Diffuse Glioma Molecular Subtypes. Journal of Clinical Medicine. 2021; 10(4):598.
https://doi.org/10.3390/jcm10040598
Chicago/Turabian Style
Richter, Vivien, Uwe Klose, Benjamin Bender, Katharina Rabehl, Marco Skardelly, Jens Schittenhelm, Ghazaleh Tabatabai, Johann-Martin Hempel, Ulrike Ernemann, and Cornelia Brendle.
2021. "Dynamic Susceptibility Perfusion Imaging for Differentiating Progressive Disease from Pseudoprogression in Diffuse Glioma Molecular Subtypes" Journal of Clinical Medicine 10, no. 4: 598.
https://doi.org/10.3390/jcm10040598
APA Style
Richter, V., Klose, U., Bender, B., Rabehl, K., Skardelly, M., Schittenhelm, J., Tabatabai, G., Hempel, J. -M., Ernemann, U., & Brendle, C.
(2021). Dynamic Susceptibility Perfusion Imaging for Differentiating Progressive Disease from Pseudoprogression in Diffuse Glioma Molecular Subtypes. Journal of Clinical Medicine, 10(4), 598.
https://doi.org/10.3390/jcm10040598
